Table 2d. The relationship between patient characteristics, mGPS and survival in patients sampled within 2 months before cancer diagnosis in the Glasgow Inflammation Outcome Study.
|
Overall survival
|
Cancer-specific survival
|
|||||
|---|---|---|---|---|---|---|
| n=5397 | HR | 95 % CI | P-value | HR | 95 % CI | P-value |
| Age | ||||||
| ⩽65 years | 1 | <0.001 | 1 | <0.001 | ||
| 65–74 years | 1.31 | 1.20–1.42 | <0.001 | 1.22 | 1.12–1.33 | <0.001 |
| ⩾75 years | 1.92 | 1.76–2.10 | <0.001 | 1.70 | 1.55–1.87 | <0.001 |
| Sex | ||||||
| Male | 1 | 0.340 | 1 | 0.507 | ||
| Female | 0.96 | 0.340 | 0.97 | 0.507 | ||
| SIMD | ||||||
| 1 (least deprived) | 1 | <0.001 | 1 | <0.001 | ||
| 2 | 1.05 | 0.503 | 1.08 | 0.364 | ||
| 3 | 1.07 | 0.342 | 1.11 | 0.179 | ||
| 4 | 1.20 | 1.06–1.36 | 0.005 | 1.20 | 1.05–1.38 | 0.008 |
| 5 (most deprived) | 1.30 | 1.16–1.45 | <0.001 | 1.28 | 1.14–1.45 | <0.001 |
| mGPS | ||||||
| 0 | 1 | <0.001 | 1 | <0.001 | ||
| 1 | 1.67 | 1.53–1.83 | <0.001 | 1.74 | 1.59–1.91 | <0.001 |
| 2 | 2.36 | 2.15–2.59 | <0.001 | 2.40 | 2.17–2.65 | <0.001 |
Abbreviations: HR=hazard ratio; CI=confidence interval; SIMD=Scottish Index of Multiple Deprivation; mGPS=modified Glasgow Prognostic Score.
Multivariate analysis stratified by tumour site.